This helps reduce inflammation and MS symptoms. Treatment may include: Healthcare professionals typically give high dose steroids through an IV once daily for 3 to 5 days. This usually occurs in ...

Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

[1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR-BHPR guidelines suggesting an initial prednisone dose comprised between 15 and 20 mg as appropriate. [2] However ...

About 43% of patients with sarcoidosis received treatment within 1 year of diagnosis, according to study findings published in Chest. Researchers evaluated treatment rates, treatm ...

U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...

Incyte (Nasdaq:INCY) and Syndax Pharmaceuticals (Nasdaq:SNDX) today announced that the U.S. Food and Drug Administration (FDA) has approved Niktimvo™ (axatilimab-csfr) in 9 mg and 22 mg vial sizes.

US FDA approves Incyte and Syndax’s Niktimvo 9 mg & 22 mg vial sizes to treat chronic graft-versus-host disease: Wilmington, Delaware Friday, January 17, 2025, 13:30 Hrs [IST] I ...

The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

A medical professional has issued a warning about a common sign of cancer that can manifest during sleep. The doctor, who ...

Michael Cochran’s friends said his wife gave a range of conflicting stories to explain Michael’s sudden unresponsive state on ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...